DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community

Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Study ID
NCT07521722
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Alzheimer Disease
  • Cognitive Dysfunction, Cognitive Disorder
  • Dementia
  • Neurodegenerative Disease

Eligibility Criteria

Sex
ALL
Age
50 Years - 75 Years
Healthy Volunteers
Accepted

Study Details

The DIV-AD study aims to find out whether levels of Alzheimer's disease markers in blood differ among the main ethnical groups living in central Barcelona. It will also examine how factors such as age, income, education, and health conditions may affect these levels. In addition, the study will identify barriers that may make it difficult to use these blood tests in primary care. The final goal is to help ensure that everyone in Barcelona has fair access to early prevention strategies for Alzheimer's disease.

Key Dates

First listed
Apr 13, 2026
Start date
Apr 27, 2026
Status verified
Feb 2026
Primary completion
Apr 27, 2027
Completion
Jan 1, 2029

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: European
    50 participants from any European country
  • Arm: South Asian
    50 participants from Pakistan, India, Bangladesh
  • Arm: Filipinos
    50 participants from Philippines
  • Arm: Latin America
    50 participants from any country of South America
  • Arm: Maghrebi
    50 participants from any country of the Magheb region (Morocco, Tunisia, Mauritania, Algeria, Libya)

Primary Outcome Measure

Plasma levels of Alzheimer's disease blood-based biomarkers across ethnic groups [ Time Frame: Through study completion, an average of 1 year ]

Central Contacts

Find similar trials

Nationwide
Alzheimer's disease trialsNeurology trialsDementia care trialsBrain disorders trialsGeriatrics trials

Related Studies